Gene · 10645
Papers2,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Physicochemical Attributes of Solid Hyaluronic Acid Technology Platform-Based Film Drive Rapid Oral Permeation and Barrier Enhancement via LKB1/CaMKKβ-AMPK Signaling. | ACS Omega | 2026 | 42255537 | PubTator, text mining | PubMed |
| Advances in targeted treatment of ferroptosis in diabetic kidney disease with SGLT2 inhibitors. | Diabetol Metab Syndr | 2026 | 42216164 | PubTator, text mining | PubMed |
| A CAMKK2-UBR4-19S Proteasome Axis Regulates Chondrocyte Proteostasis and SOX9 Stability. | bioRxiv | 2026 | 42182340 | PubTator, text mining | PubMed |
| Gasdermin C reprograms metabolism through the CAMKK2-AMPK axis to promote lung adenocarcinoma progression and radioresistance. | Cell Rep | 2026 | 42176271 | PubTator, text mining | PubMed |
| A multi species autophagy-inducing nano-vaccine platform: uncovering immunoenhancement properties of PCV2 cap nanoparticles. | J Nanobiotechnology | 2026 | 42106834 | PubTator, text mining | PubMed |
| Illuminating compartmentalized AMPK signaling in single cells. | Biochem J | 2026 | 42093562 | PubTator, text mining | PubMed |
| Stanniocalcin-1 confers neuroprotection against ischemic injury via calreticulin-dependent activation of the CAMKK2/AMPK/GSK-3β/Nrf2 pathway. | J Cereb Blood Flow Metab | 2026 | 42093271 | PubTator, text mining | PubMed |
| A phosphorylation switch at MRE11 links ATM-ATR and calcium signaling to safeguard stalled replication fork stability. | Res Sq | 2026 | 42078910 | PubTator, text mining | PubMed |
| TPD52 inhibits aldosterone synthesis through suppression of CAMKK2 signaling. | Eur J Endocrinol | 2026 | 42065138 | PubTator, text mining | PubMed |
| The cytotoxic effect of prexasertib is a consequence of dual inhibition on both CHK1 and AMPK. | Cell Chem Biol | 2026 | 42061410 | PubTator, text mining | PubMed |
| Exploiting autophagy-targeting natural compounds for potential antimicrobial actions. | Autophagy | 2026 | 42047332 | PubTator, text mining | PubMed |
| DNA Methylation Regulates CDK5R1 and NRBP1 to Exert Effects on Alcohol Dependence: Insights From Mendelian Randomization. | Addict Biol | 2026 | 42025296 | PubTator, text mining | PubMed |
| AMPK as a Double-Edged sword in cancer: role of natural compounds in its regulation. | Nat Prod Res | 2026 | 41962135 | PubTator, text mining | PubMed |
| Identification of biomarkers associated with endoplasmic reticulum stress-related cell death in osteoporosis based on bulk and single-cell transcriptomic analyses and experimental validation. | Sci Rep | 2026 | 41905994 | PubTator, text mining | PubMed |
| Anoikis-Related Genes Signature Contributes to Predicting Prognosis and Response to Immunotherapy in Lung Squamous Cell Carcinoma. | Med Sci Monit | 2026 | 41902322 | PubTator, text mining | PubMed |
| Autophagy: From Molecular Mechanisms to Disease Regulation and Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41899437 | PubTator, text mining | PubMed |
| The Polyphenol-Microbiota Axis: Molecular Mechanisms, Metabolic Pathways, and Therapeutic Perspectives in Human Health. | J Pers Med | 2026 | 41893010 | PubTator, text mining | PubMed |
| Unveiling lactylation: A novel frontier in the pathogenesis of diabetic nephropathy (Review). | Int J Mol Med | 2026 | 41891971 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
| Metabolic rewiring through succinate-GPR91 signaling: a fresh perspective on HFpEF energetics. | Cardiovasc Diabetol | 2026 | 41872865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10645/papers?page=2